🎗️ Oncology Papers

Scholarly works matching "oncology" in Crossref, sorted by the number of times other DOI-registered works cite them. Citation counts come from Crossref and are usually lower than Google Scholar figures.

575 top-cited papers indexed

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

D. Planchard, S. Popat et al. (2018)

Annals of Oncology

1.9K citesjournal articlePDF

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

M Al-Sarraf, M LeBlanc et al. (1998)

Journal of Clinical Oncology

1.8K citesjournal articlePDF

Metastatic Behavior of Breast Cancer Subtypes

Hagen Kennecke, Rinat Yerushalmi et al. (2010)

Journal of Clinical Oncology

1.9K citesjournal articlePDF

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

Richard M. Goldberg, Daniel J. Sargent et al. (2004)

Journal of Clinical Oncology

1.8K citesjournal articlePDF

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

F. Cardoso, S. Kyriakides et al. (2019)

Annals of Oncology

1.9K citesjournal articlePDF

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

J.B.A.G. Haanen, F. Carbonnel et al. (2017)

Annals of Oncology

1.9K citesjournal articlePDF

Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy

Carsten Denkert, Gunter von Minckwitz et al. (2018)

The Lancet Oncology

2.0K citesjournal articlePDF

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update

Bryan J. Schneider, Jarushka Naidoo et al. (2021)

Journal of Clinical Oncology

2.2K citesjournal articlePDF

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

Dirk Schadendorf, F. Stephen Hodi et al. (2015)

Journal of Clinical Oncology

1.9K citesjournal articlePDF

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

Robert J. Motzer, Thomas E. Hutson et al. (2009)

Journal of Clinical Oncology

1.8K citesjournal articlePDF

International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes

International T-Cell Lymphoma Project (2008)

Journal of Clinical Oncology

1.9K citesjournal articlePDF

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

Quinn T. Ostrom, Haley Gittleman et al. (2015)

Neuro-Oncology

1.9K citesjournal article

Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

Daniel Y.C. Heng, Wanling Xie et al. (2009)

Journal of Clinical Oncology

1.8K citesjournal articlePDF

Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer

Michael J. Overman, Sara Lonardi et al. (2018)

Journal of Clinical Oncology

1.9K citesjournal articlePDF

American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer

Lyndsay Harris, Herbert Fritsche et al. (2007)

Journal of Clinical Oncology

1.8K citesjournal articlePDF